Research ArticleOriginal Article
Open Access

Altered plasma glutamate and glutamine levels in patients with drug-resistant and drug-responsive symptomatic focal epilepsy

Wei Wang, Yanchuan Wu, Xiaoling Li, Lin Li, Ke Sun and Suying Yan
Neurosciences Journal October 2021, 26 (4) 315-322; DOI: https://doi.org/10.17712/nsj.2021.4.20210041

References

  1. 1.↵
    1. Farrelly AM,
    2. Vlachou S,
    3. Grintzalis K.
    Efficacy of phytocannabinoids in epilepsy treatment: novel approaches and recent advances. Int J Environ Res Public Health 2021; 18: 3993.
    OpenUrl
  2. 2.↵
    1. Leke R,
    2. Schousboe A.
    The glutamine transporters and their role in the glutamate/GABA-glutamine cycle. Adv Neurobiol 2016; 13: 223–257.
    OpenUrl
  3. 3.↵
    1. Robinson MB,
    2. Jackson JG.
    Astroglial glutamate transporters coordinate excitatory signaling and brain energetics. Neurochem Int 2016; 98: 56–71.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Alcoreza OB,
    2. Patel DC,
    3. Tewari BP,
    4. Sontheimer H.
    Dysregulation of ambient glutamate and glutamate receptors in epilepsy: an astrocytic perspective. Front Neurol 2021; 12: 652159.
    OpenUrl
  5. 5.
    1. Peterson AR,
    2. Binder DK.
    Astrocyte glutamate uptake and signaling as novel targets for antiepileptogenic therapy. Front Neurol 2020; 11: 1006.
    OpenUrl
  6. 6.↵
    1. Price JB,
    2. Rusheen AE,
    3. Barath AS,
    4. Rojas Cabrera JM,
    5. Shin H,
    6. Chang SY, et al.
    Clinical applications of neurochemical and electrophysiological measurements for closed-loop neurostimulation. Neurosurg Focus 2020; 49: E6.
    OpenUrl
  7. 7.↵
    1. Hashimoto K,
    2. Bruno D,
    3. Nierenberg J,
    4. Marmar CR,
    5. Zetterberg H,
    6. Blennow K, et al.
    Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study. Transl Psychiatry 2016; 6: e744.
    OpenUrl
  8. 8.↵
    1. Madeira C,
    2. Vargas-Lopes C,
    3. Brandão CO,
    4. Reis T,
    5. Laks J,
    6. Panizzutti R, et al.
    Elevated glutamate and glutamine levels in the cerebrospinal fluid of patients with probable alzheimer’s disease and depression. Front Psychiatry 2018; 9: 561.
    OpenUrl
  9. 9.↵
    1. Kwan P,
    2. Arzimanoglou A,
    3. Berg AT,
    4. Brodie MJ,
    5. Allen Hauser W,
    6. Mathern G, et al.
    Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 2010; 51: 1069–1077.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Siddiqui A,
    2. Kerb R,
    3. Weale ME,
    4. Brinkmann U,
    5. Smith A,
    6. Goldstein DB, et al.
    Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 2003; 348: 1442–1448.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Kumar R,
    2. Indrayan A.
    Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr 2011; 48: 277–287.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Çavuş I,
    2. Romanyshyn JC,
    3. Kennard JT,
    4. Farooque P,
    5. Williamson A,
    6. Eid T, et al.
    Elevated basal glutamate and unchanged glutamine and GABA in refractory epilepsy: microdialysis study of 79 patients at the yale epilepsy surgery program. Ann Neurol 2016; 80: 35–45.
    OpenUrl
  13. 13.↵
    1. Kanamori K,
    2. Ross BD.
    Chronic electrographic seizure reduces glutamine and elevates glutamate in the extracellular fluid of rat brain. Brain Res 2011; 1371: 180–191.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Cavus I,
    2. Kasoff WS,
    3. Cassaday MP,
    4. Jacob R,
    5. Gueorguieva R,
    6. Sherwin RS, et al.
    Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann Neurol 2005; 57: 226–235.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Zavvari F,
    2. Modarres Mousavi SM,
    3. Ejlali M,
    4. Barfi S,
    5. Karimzadeh F.
    Glutamate Signaling pathway in absence epilepsy: possible role of ionotropic AMPA glutamate receptor type 1 subunit. Iran J Pharm Res 2020; 19: 410–418.
    OpenUrl
  16. 16.↵
    1. Sandhu MRS,
    2. Gruenbaum BF,
    3. Gruenbaum SE,
    4. Dhaher R,
    5. Deshpande K,
    6. Funaro MC, et al.
    Astroglial glutamine synthetase and the pathogenesis of mesial temporal lobe epilepsy. Front Neurol 2021; 12: 665334.
    OpenUrl
  17. 17.↵
    1. Todd AC,
    2. Hardingham GE.
    The regulation of astrocytic glutamate transporters in health and neurodegenerative diseases. Int J Mol Sci 2020; 21: 9607.
    OpenUrl
  18. 18.↵
    1. Passlick S,
    2. Rose CR,
    3. Petzold GC,
    4. Henneberger C.
    Disruption of glutamate transport and homeostasis by acute metabolic stress. Front Cell Neurosci 2021; 15: 637784.
    OpenUrl
  19. 19.↵
    1. Alleva C,
    2. Machtens JP,
    3. Kortzak D,
    4. Weyand I,
    5. Fahlke C.
    Molecular basis of coupled transport and anion conduction in excitatory amino acid transporters. Neurochem Res 2021 Feb.
  20. 20.↵
    1. Wang H,
    2. Huang Y,
    3. Coman D,
    4. Munbodh R,
    5. Dhaher R,
    6. Zaveri HP, et al.
    Network evolution in mesial temporal lobe epilepsy revealed by diffusion tensor imaging. Epilepsia 2017; 58: 824–834.
    OpenUrl
  21. 21.↵
    1. Eid T,
    2. Lee TW,
    3. Patrylo P,
    4. Zaveri HP.
    Astrocytes and glutamine synthetase in epileptogenesis. J Neurosci Res 2019; 97: 1345–1362.
    OpenUrlCrossRef
  22. 22.↵
    1. Sun HL,
    2. Zhu W,
    3. Zhang YR,
    4. Pan XH,
    5. Zhang JR,
    6. Chen XM, et al.
    Altered glutamate metabolism contributes to antiepileptogenic effects in the progression from focal seizure to generalized seizure by low-frequency stimulation in the ventral hippocampus. Epilepsy Behav 2017; 68: 1–7.
    OpenUrl
  23. 23.↵
    1. Rossetti MF,
    2. Cambiasso MJ,
    3. Holschbach MA,
    4. Cabrera R.
    Oestrogens and progestagens: synthesis and action in the brain. J Neuroendocrinol 2016; 28.
  24. 24.↵
    1. Maltais-Payette I,
    2. Boulet MM,
    3. Prehn C,
    4. Adamski J,
    5. Tchernof A.
    Circulating glutamate concentration as a biomarker of visceral obesity and associated metabolic alterations. Nutr Metab (Lond) 2018; 15: 78.
    OpenUrl
  25. 25.↵
    1. Luna-Munguia H,
    2. Zestos AG,
    3. Gliske SV,
    4. Kennedy RT,
    5. Stacey WC.
    Chemical biomarkers of epileptogenesis and ictogenesis in experimental epilepsy. Neurobiol Dis 2019; 121: 177–186.
    OpenUrl
  26. 26.↵
    1. Luna-Munguía H,
    2. Meneses A,
    3. Peña-Ortega F,
    4. Gaona A,
    5. Rocha L.
    Effects of hippocampal high-frequency electrical stimulation in memory formation and their association with amino acid tissue content and release in normal rats. Hippocampus 2012; 22: 98–105.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Rogawski MA,
    2. Löscher W,
    3. Rho JM.
    Mechanisms of action of antiseizure drugs and the ketogenic diet. Cold Spring Harb Perspect Med 2016; 6: a022780.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. van Veenendaal TM,
    2. IJff DM,
    3. Aldenkamp AP,
    4. Lazeron RHC,
    5. Puts NAJ,
    6. Edden RAE, et al.
    Glutamate concentrations vary with antiepileptic drug use and mental slowing. Epilepsy Behav 2016; 64: 200–205.
    OpenUrl
  29. 29.
    1. Leite CDC,
    2. Valente KDR,
    3. Fiore LA,
    4. Otaduy MCG.
    Proton spectroscopy of the thalamus in a homogeneous sample of patients with easy-to-control juvenile myoclonic epilepsy. Radiol Bras 2017; 50: 279–284.
    OpenUrl
  30. 30.↵
    1. Pichardo Macías LA,
    2. Ramírez Mendiola BA,
    3. Contreras García IJ,
    4. Zamudio Hernández SR,
    5. Chávez Pacheco JL,
    6. Sánchez Huerta KB, et al.
    Effect of levetiracetam on extracellular amino acid levels in the dorsal hippocampus of rats with temporal lobe epilepsy. Epilepsy Res 2018; 140: 111–119.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section